Octagon Capital Advisors LP ARRIVENT BIOPHARMA INC Transaction History
Octagon Capital Advisors LP
- $433 Million
- Q2 2024
Number of Shares
1,803,304
Previous 1,943,836
7.23%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%